Experimental reproduction of postweaning multisystemic wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate of porcine circovirus type 2.
An experimental model using 3-day-old snatch-farrowed colostrum-deprived piglets co-infected with porcine circovirus type 2 (PCV2) and porcine parvovirus (PPV) is at present one of the best methods to study factors affecting development of postweaning multisystemic wasting syndrome (PMWS). A Swedish isolate of PCV2 (S-PCV2) retrieved in 1993 from a healthy pig has been used in this model to reproduce PMWS in pigs from Northern Ireland. This virus has been present in the Swedish pig population for at least a decade without causing any known PMWS disease problems, despite its potential pathogenicity. The reasons for this are unknown, but could be related to genetics, absence of triggers for PCV2 upregulation (infectious agent and/or management forms) within Swedish pig husbandry. In order to confirm the pathogenicity of S-PCV2, Swedish and Danish pigs were experimentally infected with this isolate according to the established model. Swedish pigs were also infected with a reference isolate of PCV2 (PCV2-1010) to compare the severity of disease caused by the two isolates in Swedish pigs. Both Danish and Swedish pigs developed PMWS after the experimental infection with S-PCV2. Antibodies to PCV2 developed later and reached lower levels in serum from pigs infected with S-PCV2 than in pigs inoculated with PCV2-1010. In general, pigs infected with S-PCV2 showed more severe clinical signs of disease than pigs infected with PCV2-1010, but pigs from all PCV2-inoculated groups displayed gross and histological lesions consistent with PMWS. All pigs inoculated with PPV, alone or in combination with PCV2, displayed interleukin-10 responses in serum while only pigs infected with PPV in combination with PCV2 showed interferon-alpha in serum on repeated occasions. Thus, the pathogenicity of S-PCV2 was confirmed and a role for cytokines in the etiology of PMWS was indicated.
Hasslung
F
F
Department of Molecular Biosciences, Section of Veterinary Immunology and Virology, Swedish University of Agricultural Sciences, Biomedical Centre, PO Box 588, SE-751 23 Uppsala, Sweden. frida.hasslung@vmm.slu.se
Wallgren
P
P
Ladekjaer-Hansen
A-S
AS
Bøtner
A
A
Nielsen
J
J
Wattrang
E
E
Allan
G M
GM
McNeilly
F
F
Ellis
J
J
Timmusk
S
S
Belák
K
K
Segall
T
T
Melin
L
L
Berg
M
M
Fossum
C
C
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D000956:Antigens, Viral / Q000032:analysis; D001831:Body Temperature; D001835:Body Weight; D018173:Circoviridae Infections / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D017925:Circovirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D003718:Denmark; D006651:Histocytochemistry / Q000662:veterinary; D016898:Interferon-alpha / Q000097:blood; D016753:Interleukin-10 / Q000097:blood; D010322:Parvoviridae Infections / Q000276:immunology / Q000662:veterinary / Q000821:virology; D028323:Parvovirus, Porcine / Q000276:immunology; D016133:Polymerase Chain Reaction / Q000662:veterinary; D013548:Sweden; D013552:Swine; D013553:Swine Diseases / Q000276:immunology / Q000821:virology*; D014774:Virulence; D019282:Wasting Syndrome / Q000276:immunology / Q000662:veterinary* / Q000821:virology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D004279:DNA, Viral; D016898:Interferon-alpha; D016753:Interleukin-10
Vet Microbiol. 2004 Feb 4;98(2):165-8
14741129
J Vet Diagn Invest. 1998 Jan;10(1):3-10
9526853
J Vet Med B Infect Dis Vet Public Health. 2000 Mar;47(2):81-94
10763376
Prev Vet Med. 2003 Nov 12;61(3):209-25
14554144
Vet Microbiol. 2004 Mar 5;98(3-4):209-20
15036529
Immunol Lett. 2004 May 15;93(2-3):97-108
15158604
Scand J Immunol. 1995 Feb;41(2):121-9
7863258
Vet Microbiol. 2002 Oct 22;89(2-3):97-114
12243888
J Vet Diagn Invest. 2000 Sep;12(5):400-5
11021425
Vet Microbiol. 2004 Feb 4;98(2):131-5
14741125
J Vet Med B Infect Dis Vet Public Health. 2003 Mar;50(2):99-101
12675903
Vet Microbiol. 1997 Jan;54(1):1-16
9050166
Vet Immunol Immunopathol. 2004 May;99(1-2):63-71
15113655
Vet Microbiol. 2004 Feb 4;98(2):159-63
14741128
Vet Pathol. 2000 May;37(3):254-63
10810990
Can Vet J. 1998 Jan;39(1):44-51
9442952
Arch Virol. 2001;146(5):909-22
11448029
Arch Virol. 2000;145(11):2421-9
11205128
J Gen Virol. 2003 Dec;84(Pt 12):3453-3457
14645926
J Gen Virol. 2004 Feb;85(Pt 2):293-304
14769887
J Gen Virol. 2003 Aug;84(Pt 8):2117-2125
12867643
J Comp Pathol. 2003 Aug-Oct;129(2-3):205-12
12921727
Viral Immunol. 2002;15(4):549-56
12513926
J Gen Virol. 1998 Sep;79 ( Pt 9):2171-9
9747726
Vet Microbiol. 2002 May 24;86(4):281-93
11955778
J Vet Diagn Invest. 2002 Nov;14(6):449-56
12423025
Can J Vet Res. 2003 May;67(2):114-20
12760476
J Vet Diagn Invest. 2003 Nov;15(6):553-60
14667018
J Gen Virol. 2003 Oct;84(Pt 10):2755-2760
13679610
J Comp Pathol. 1999 Jul;121(1):1-11
10373289
J Vet Med B Infect Dis Vet Public Health. 2000 Nov;47(9):663-75
11244867